Schedules of Controlled Substances: Table of Excluded Nonnarcotic Products: Vicks® VapoInhaler®.
Fed Regist
; 81(25): 6451-3, 2016 Feb 08.
Article
em En
| MEDLINE
| ID: mdl-26859905
ABSTRACT
This final rule adopts the interim final rule, with a correction to spelling of the manufacturer's name that was published in the Federal Register on October 27, 2015. The Drug Enforcement Administration is amending the table of Excluded Nonnarcotic Products to update the listing for Vicks® VapoInhaler®, containing 50 mg levmetamfetamine in a nasal decongestant inhaler, marketed by The Procter & Gamble Company. This over-the-counter, non-narcotic drug product is excluded from provisions of the Controlled Substances Act.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Descongestionantes Nasais
/
Nebulizadores e Vaporizadores
/
Controle de Medicamentos e Entorpecentes
/
Metanfetamina
Limite:
Humans
País/Região como assunto:
America do norte
Idioma:
En
Revista:
Fed Regist
Ano de publicação:
2016
Tipo de documento:
Article